FDA Envisions International Focus Groups Navigating Globalization Issues
This article was originally published in The Tan Sheet
Executive Summary
FDA could help create several international coalitions to carry out the agency’s globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors.
You may also be interested in...
FDA’s New Criminal Investigations Chief Wants Global Reach
Office of Criminal Investigations Director George Karavetsos talks about the Park Doctrine and off-label enforcement in an interview.
Trusted Trader Program Pairs FDA With Customs To Expedite Imports
The Trusted Trader program would create some incentives to companies willing to ensure their supply chains are secure, but is similar to a program FDA already has in place.
Trusted Trader Program Pairs FDA With Customs To Expedite Imports
The Trusted Trader program would create some incentives to companies willing to ensure their supply chains are secure, but is similar to a program FDA already has in place.